Sudbury, MA, United States of America

Ronald Charles Tomlinson


 

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 51(Granted Patents)


Location History:

  • Marlborough, MA (US) (2005 - 2010)
  • Sudbury, MA (US) (2007 - 2016)

Company Filing History:


Years Active: 2005-2016

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ronald Charles Tomlinson: A Pioneer in Tankyrase Inhibitor Research

Introduction

Ronald Charles Tomlinson, an inventive mind located in Sudbury, MA, is known for his significant contributions to pharmaceutical science through his innovative patenting efforts. With a remarkable portfolio comprising eight patents, Tomlinson has focused primarily on developing compounds that address critical health issues, particularly those related to cancer through tankyrase inhibition.

Latest Patents

Among his latest innovations is a patent for 4-oxo-3,5,7,8-tetrahydro-4H-pyrano[4,3-d]pyrmidinyl compounds, designed for use as tankyrase inhibitors. This invention encompasses a range of compounds that have demonstrated potential in the treatment of Wnt signaling and disorders related to tankyrase 1 and 2 signaling, with applications in cancer therapies. Another notable patent by Tomlinson includes 2-piperidin-1-yl-acetamide compounds, which also function as tankyrase inhibitors, further solidifying his role in advancing pharmacological research aimed at combating cancer.

Career Highlights

Tomlinson’s career boasts impressive affiliations with prominent companies in the pharmaceutical sector. He has made substantial contributions while working at Vertex Pharmaceuticals, Inc., and Novartis AG, two leaders in innovative drug development. Through his work, he has not only contributed to product development but has also ensured significant innovations in cancer treatment options.

Collaborations

Throughout his career, Tomlinson has collaborated with talented individuals in the field, such as David J. Lauffer and Alex Aronov. These partnerships have likely played a crucial role in the successful development of his patents and have contributed to his impactful presence in the industry.

Conclusion

Ronald Charles Tomlinson remains a critical figure in the realm of innovative medical research, particularly through his patented work in the development of tankyrase inhibitors. His collaborations, career experiences, and groundbreaking inventions mark him as an influential inventor committed to improving cancer treatment and enhancing pharmaceutical methodologies. As research continues to evolve, Tomlinson’s contributions will undoubtedly pave the way for future advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…